Literature DB >> 10022755

Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquine.

C Sachse1, J Brockmöller, M Hildebrand, K Müller, I Roots.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10022755

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  10 in total

1.  Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.

Authors:  Myo-Kyoung Kim; Joo-Youn Cho; Hyeong-Seok Lim; Kyoung-Seop Hong; Jae-Yong Chung; Kyun-Seop Bae; Dal-Seok Oh; Sang-Goo Shin; Sang-Hun Lee; Dong-Ho Lee; Bumchan Min; In-Jin Jang
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

Review 2.  Implications of pharmacogenetics for individualizing drug treatment and for study design.

Authors:  Christian Meisel; Thomas Gerloff; Julia Kirchheiner; Przemyslaw M Mrozikiewicz; Przemyslaw Niewinski; Jürgen Brockmöller; Ivar Roots
Journal:  J Mol Med (Berl)       Date:  2003-03-15       Impact factor: 4.599

3.  CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.

Authors:  S McElroy; C Sachse; J Brockmoller; J Richmond; M Lira; D Friedman; I Roots; B M Silber; P M Milos
Journal:  AAPS PharmSci       Date:  2000

4.  Fatal intoxication cases: cytochrome P450 2D6 and 2C19 genotype distributions.

Authors:  A L Zackrisson; P Holmgren; A B Gladh; J Ahlner; B Lindblom
Journal:  Eur J Clin Pharmacol       Date:  2004-09-02       Impact factor: 2.953

5.  Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.

Authors:  Katja Grasmäder; Petra Louise Verwohlt; Marcella Rietschel; Aleksandra Dragicevic; Matthias Müller; Christoph Hiemke; Nikolaus Freymann; Astrid Zobel; Wolfgang Maier; Marie Luise Rao
Journal:  Eur J Clin Pharmacol       Date:  2004-05-28       Impact factor: 2.953

6.  Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation.

Authors:  S Martis; H Mei; R Vijzelaar; L Edelmann; R J Desnick; S A Scott
Journal:  Pharmacogenomics J       Date:  2012-11-20       Impact factor: 3.550

7.  Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.

Authors:  Rula Y Qumsieh; Bassam R Ali; Yousef M Abdulrazzaq; Ossama Osman; Nadia A Akawi; Salim M A Bastaki
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

8.  Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

Authors:  H Fang; X Liu; J Ramírez; N Choudhury; M Kubo; H K Im; A Konkashbaev; N J Cox; M J Ratain; Y Nakamura; P H O'Donnell
Journal:  Pharmacogenomics J       Date:  2014-07-01       Impact factor: 3.550

9.  Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.

Authors:  Jens Borggaard Larsen; Jan Borg Rasmussen
Journal:  Pharmgenomics Pers Med       Date:  2017-04-18

10.  Prediction and visualization of CYP2D6 genotype-based phenotype using clustering algorithms.

Authors:  Eun-Young Kim; Sang-Goo Shin; Jae-Gook Shin
Journal:  Transl Clin Pharmacol       Date:  2017-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.